跳到正文

BTAI — Bioxcel Therapeutics Inc 机构持仓 · 2026年Q2

谁持有 Bioxcel Therapeutics Inc(BTAI)?2026年Q2(报告期截至 2026-06-30)共有 48 家机构在 SEC 13F 申报中报告持有,合计 868.61 万美元。前几大持有机构:千禧管理(300.00 万美元)、Oaktree Capital Management LP(190.00 万美元)、先锋领航(150.00 万美元)。

排名机构市值股数变动
1MILLENNIUM MANAGEMENT LLC$3.0M2.1M增持
2OAKTREE CAPITAL MANAGEMENT LP$1.9M1.4M增持
3VANGUARD GROUP INC$1.5M1.1M增持
4Oaktree Fund Advisors, LLC$346,274245,585增持
5GEODE CAPITAL MANAGEMENT, LLC$341,911242,251增持
6BlackRock, Inc.$253,001179,433增持
7UBS Group AG$222,871158,065增持
8CITADEL ADVISORS LLC$210,400149,220新建仓
9STATE STREET CORP$129,88692,118持平
10FMR LLC$127,32390,300持平
11&PARTNERS$117,85983,588增持
12JONES FINANCIAL COMPANIES LLLP$82,71263,139减持
13NORTHERN TRUST CORP$79,40856,318增持
14HighTower Advisors, LLC$57,81041,000持平
15Quadrature Capital Ltd$53,63438,038新建仓
16Headlands Technologies LLC$36,03425,556新建仓
17StoneX Group Inc.$29,16420,684新建仓
18Beacon Pointe Advisors, LLC$26,56118,837减持
19SUSQUEHANNA INTERNATIONAL GROUP, LLP$24,25217,200新建仓
20Portfolio Strategies, Inc.$23,73216,831增持
21Virtu Financial LLC$23,00015,967新建仓
22OSAIC HOLDINGS, INC.$22,86016,214持平
23TWO SIGMA SECURITIES, LLC$15,22210,796新建仓
24Diversify Advisory Services, LLC$13,00515,000新建仓
25DIVERSIFY WEALTH MANAGEMENT, LLC$13,00515,000持平

来源:SEC 13F 申报文件 · 截至 2026-06-30